- CFO Spotlights
- Profiles
- Brendan Hannah
Profile
Brendan Hannah
Chief Business Officer and Chief Operating Officer and Chief Compliance Officer (Principal Financial Officer and Principal Accounting Officer), IRulya Therapeutics Inc.
A later filing names a successor. First published here October 28, 2026; built from records as of October 28, 2026.
Brendan Hannah signed the annual report of IRulya Therapeutics Inc. on Form 10-K as Chief Business Officer and Chief Operating Officer and Chief Compliance Officer (Principal Financial Officer and Principal Accounting Officer), filed April 10, 2026.1 A later filing by IRulya Therapeutics Inc., made on July 31, 2026, names John Militello as its chief financial officer; the record holds no filing that reports the end of Brendan Hannah's tenure.
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| IRulya Therapeutics Inc. (QNCX) Biological Products, (No Diagnostic Substances) | Chief Business Officer and Chief Operating Officer and Chief Compliance Officer (Principal Financial Officer and Principal Accounting Officer) | A later filing names a successor John Militello, filed July 31, 2026 (filing) |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- April 10, 202610-K filed
Brendan Hannah signed the annual report of IRulya Therapeutics Inc. on Form 10-K as Chief Business Officer and Chief Operating Officer and Chief Compliance Officer (Principal Financial Officer and Principal Accounting Officer), filed April 10, 2026.
/s/ Brendan Hannah Chief Business Officer and Chief Operating Officer and Chief Compliance Officer April 10, 2026 Brendan Hannah (Principal Financial Officer and Principal Accounting Officer)
[1] Annual report on Form 10-K by IRulya Therapeutics Inc., filed with the SEC on April 10, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, IRulya Therapeutics Inc.. U.S. Securities and Exchange Commission, EDGAR, filed April 10, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Brendan Hannah wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.